Cipla, Aurobindo, Viatris in licensing pact with MPP to produce generic versions of ViiV Healthcare HIV drug Ruchika Sharma31 March 2023 3:09 PM ISTAurobindo and Viatris will manufacture in India; Cipla will manufacture in India and has plans to manufacture in South Africa as well.
XTANDI plus Leuprolide improves Metastasis-Free survival in men with non-metastatic prostate cancer: Pfizer Ruchika Sharma20 March 2023 11:50 AM ISTXTANDI (enzalutamide) is an androgen receptor signaling inhibitor.
Pfizer to replace migraine drug Nurtec ODT packaging over child safety concerns Ruchika Sharma18 March 2023 11:00 AM ISTAs an interim measure, the company has instructed pharmacists to place the drug packet in a child-resistant vial before dispensing it to patients.
Glenmark Pharma bags USFDA nod for generic version of Cleocin Hydrochloride Capsules Ruchika Sharma16 March 2023 11:15 AM ISTClindamycin Hydrochloride capsules are used for the treatment of bacterial infections of the skin, blood, lungs, female reproductive organs, and...
Pfizer gets USFDA emergency use nod for Omicron BA.4/BA.5-adapted bivalent COVID booster in children under 5 years Ruchika Sharma15 March 2023 12:15 PM ISTThe Pfizer-BioNTech COVID-19 Vaccines (COMIRNATY) are based on BioNTech's proprietary mRNA technology and were developed by both BioNTech and Pfizer.
Pfizer, Bristol Myers, AbbVie drugs likely to face US price negotiation Ruchika Sharma14 March 2023 3:30 PM ISTNovo Nordisk's diabetes drug Ozempic, prostate cancer treatment Xtandi from Astellas Pharma and Pfizer, and J&J's blood thinner Xarelto are on three...
Pfizer to acquire Seagen for USD 43 billion Ruchika Sharma14 March 2023 12:00 PM ISTThe proposed acquisition is also expected to enable for combination potential across both the Seagen and Pfizer pipelines and will leverage Pfizer's...
CDSCO Panel Rejects Pfizer's Proposal to Waive Phase IV CT of Antimicrobial FDC Dr. Divya Colin13 March 2023 6:00 PM ISTNew Delhi: Highlighting that there is no unmet need for a Phase IV clinical trial study waiver, the Subject Expert Committee (SEC) functional under...
GSK, Pfizer ready to launch RSV vaccines for older adults in US Ruchika Sharma12 March 2023 2:30 PM ISTRSV is a leading cause of pneumonia in infants and the elderly, and decades of research have finally resulted in the two successful vaccines Pfizer...
Pfizer bags USFDA nod for migraine nasal spray ZAVZPRET Ruchika Sharma11 March 2023 11:15 AM ISTZAVZPRET is anticipated to be available in pharmacies in July 2023.
Alembic Pharma Hypertension drug Prazosin Hydrochloride gets USFDA okay Ruchika Sharma9 March 2023 5:15 PM ISTVadodara: Drugmaker Alembic Pharmaceuticals Limited has announced that the company has received final approval from the US Food & Drug...
Pfizer, BioNTech submit application to USFDA for emergency use nod of Omicron BA.4/BA.5-adapted bivalent COVID booster in children under 5 years Ruchika Sharma2 March 2023 4:15 PM ISTNew York: Pfizer Inc. and BioNTech SE have submitted an application to the U.S. Food and Drug Administration (FDA) for Emergency Use...
